Targeted agents and systemic therapy in hepatocellular carcinoma.


Cytotoxic chemotherapy, hormonal agents, and immunotherapy have been tested in hepatocellular cancer (HCC) with marginal efficacy to date. Recent insights into the molecular pathogenesis of HCC have identified several aberrant signaling pathways that have served as targets for novel therapeutic agents. These discoveries have been translated into the… (More)
DOI: 10.1007/978-3-642-16037-0_15


Cite this paper

@article{Ang2013TargetedAA, title={Targeted agents and systemic therapy in hepatocellular carcinoma.}, author={Celina Ang and Eileen M. O'Reilly and Ghassan K Abou-Alfa}, journal={Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer}, year={2013}, volume={190}, pages={225-46} }